Natus Medical Incorporated (NTUS) — Financial statements
Income statement, balance sheet, and cash flow for Natus Medical Incorporated — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 473↑13.9% | 416↓16.1% | 495↓6.7% | 531↑6.0% | 501 | |
| Cost of Revenue | 200↑0.3% | 199↓2.1% | 203↓10.3% | 227↑3.2% | 220 | |
| Gross Profit | 274↑26.4% | 217↓25.8% | 292↓4.0% | 304↑8.1% | 281 | |
| Operating Expenses | ||||||
| R&D Expenses | 56↓8.1% | 61↑4.4% | 59↓4.5% | 61↑18.6% | 52 | |
| General & Administrative Expenses | 53↑7.4% | 49↓17.7% | 60↓13.2% | 69↓7.7% | 74 | |
| Selling & Marketing Expenses | 116↑8.1% | 107↓16.9% | 129↓5.5% | 137↑8.3% | 126 | |
| SG&A Expenses | 169↑7.9% | 156↓17.1% | 189↓8.1% | 205↑2.4% | 201 | |
| Other Expenses | 17↑12.5% | 15↑0.5% | 15↓38.1% | 24↑27.7% | 19 | |
| Operating Expenses | 242↑4.0% | 233↓11.3% | 263↓9.9% | 291↑7.3% | 272 | |
| Total Costs & Expenses | 442↑2.3% | 432↓7.3% | 466↓10.1% | 518↑5.5% | 491 | |
| Operating Results | ||||||
| Operating Income | 21↑205.1% | -20↓28.9% | -16↑36.2% | -25↓381.8% | 9 | |
| Depreciation & Amortization | 28↓0.1% | 28↓8.5% | 31↓9.3% | 34↑12.5% | 30 | |
| EBITDA | 49↑408.1% | 10↓32.6% | 14↑71.6% | 8↓79.2% | 40 | |
| EBIT | 21↑215.3% | -18↓12.8% | -16↑35.9% | -25↓348.9% | 10 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↑48.6% | -4↑22.3% | -5↑27.4% | -6↓38.7% | -5 | |
| Interest Income | 0.00↓100.0% | 0.01↓95.6% | 0.25↓25.1% | 0.33↓21.4% | 0.43 | |
| Interest Expense | 2↓48.8% | 4↓26.0% | 5↓27.3% | 7↑33.7% | 5 | |
| Non-Operating Income | 0.00↑100.0% | -2↓374.5% | 0.65↓28.1% | 0.90↑159.7% | -2 | |
| Other Income / Expenses | -2↑0.0% | -2↑66.5% | -6↑27.4% | -8↓115.8% | -4 | |
| Income Before Tax | 19↑187.7% | -22↓3.8% | -21↑34.1% | -32↓726.4% | 5 | |
| Income Tax Expense | 6↑213.3% | -5↑2.4% | -6↑40.1% | -9↓136.7% | 25 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 13↑179.3% | -17↓6.0% | -16↑31.7% | -23↓13.0% | -20 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 13↑179.3% | -17↓6.0% | -16↑31.7% | -23↓13.0% | -20 | |
| Bottom-Line Net Income | 13↑179.3% | -17↓6.0% | -16↑31.7% | -23↓13.0% | -20 | |
| EPS (Basic) | 0.39↑179.6% | -0.49↓4.3% | -0.47↑31.9% | -0.69↓11.3% | -0.62 | |
| EPS (Diluted) | 0.39↑179.6% | -0.49↓4.3% | -0.47↑31.9% | -0.69↓11.3% | -0.62 | |
| Weighted Average Shares | 34↑1.2% | 34↓0.4% | 34↑1.8% | 33↑1.7% | 33 | |
| Weighted Average Diluted Shares | 34↑1.2% | 34↓0.4% | 34↑1.8% | 33↑1.7% | 33 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.